FDA Approves Unknown Drug — CREEKWOOD PHARMS
Creekwood Pharmaceuticals has been granted FDA approval for an Abbreviated New Drug Application (ANDA #218875), a regulatory milestone poised to enhance the company’s market share and generate new revenue streams.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day